Grants paid by The Robert & Lynda Altman Family Foundation
EIN 87-3339629 · Baltimore, MD · Form 990-PF, Part XV · NTEE T22
The Robert & Lynda Altman Family Foundation of Baltimore, MD (EIN 87-3339629) reported 14 grants paid totaling $11,851,103 to 4 recipients in tax years 2022–2024, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$11,851,103
14 grants
Recipients
4
distinct organizations
Tax years
2022–2024
3 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2022 | 2 | $4,525,684 | — |
| 2023 | 4 | $5,924,316 | — |
| 2024 | 8 | $1,401,103 | — |
Top recipients
The 4 recipients receiving the most from The Robert & Lynda Altman Family Foundation, by grants paid, out of 4 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Translational Genomics Research Institute Foundation 33-1092191 | B | Phoenix, AZ | 3 | $10,000,000 | 2023 |
| Landon School 52-0635092 | C | Bethesda, MD | 7 | $1,200,232 | 2024 |
| Smithsonian Institution 53-0206027 | C | Washington, DC | 3 | $600,871 | 2024 |
| Matthew Silverman Memorial Foundation 46-4024522 | B | Beverly Hills, CA | 1 | $50,000 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 14 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Landon School Bethesda, MD | C | $386,845 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2024 | Landon School Bethesda, MD | C | $244,183 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2024 | Landon School Bethesda, MD | C | $235,614 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2024 | Landon School Bethesda, MD | C | $209,257 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2024 | Smithsonian Institution Washington, DC | C | $200,871 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2024 | Landon School Bethesda, MD | C | $112,680 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2024 | Landon School Bethesda, MD | C | $7,524 | paid | GENERAL PURPOSE | 202543219349101704 |
| 2024 | Landon School Bethesda, MD | C | $4,129 | paid | GENERAL PURPOSE - GRANT MADE IN PUBLICLY TRADED STOCK | 202543219349101704 |
| 2023 | Translational Genomics Research Institute Foundation Phoenix, AZ | B | $3,022,490 | paid | ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE THERAPEUTIC RESEARCH PROJECT, TO BE CONDUCTED BY THE CITY OF HOPE WILL COMPREHENSIVELY TEST AND SCALE UP THE MANUFACTURE OF THE DRUG DENOMINATED AS MIR-142. THIS "MIMETIC" DRUG SIMULATES (REPLACES) THE ACTION OF A NORMAL SIGNAL THAT IS MISSING IN MPN/SAML PATIENTS. | 202433199349104828 |
| 2023 | Translational Genomics Research Institute Foundation Phoenix, AZ | B | $2,651,826 | paid | ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE DIAGNOSTIC RESEARCH PROJECT, IS TO BE CONDUCTED BY TGEN TO DEVELOP TWO DIAGNOSTIC TESTS. THE FIRST DIAGNOSTIC RESEARCH PROJECT IS TO IDENTIFY THE MOST SENSITIVE TEST FOR THE TRANSITION FROM MPN TO SAML. THE SECOND DIAGNOSTIC RESEARCH PROJECT IS TO DEVELOP AND DEPLOY AN ULTRA-RAPID WHOLE GENOMIC SEQUENCING TEST TO IDENTIFY DRUG TREATMENT OPTIONS FOR PATIENTS WHO HAVE TRANSITIONED FROM MPN TO SAML. | 202433199349104828 |
| 2023 | Smithsonian Institution Washington, DC | C | $200,000 | paid | GENERAL PURPOSE | 202433199349104828 |
| 2023 | Matthew Silverman Memorial Foundation Beverly Hills, CA | B | $50,000 | paid | GENERAL PURPOSE | 202433199349104828 |
| 2022 | Translational Genomics Research Institute Foundation Phoenix, AZ | B | $4,325,684 | paid | GENERAL PURPOSE | 202341399349100419 |
| 2022 | Smithsonian Institution Washington, DC | C | $200,000 | paid | GENERAL PURPOSE | 202341399349100419 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202543219349101704 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202433199349104828 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202341399349100419 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/873339629.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.